Vision Integrated Partners has established partnerships with Britton Vision Associates and Southwest Eye Clinic and Surgery, both based in Oklahoma City.
Ophthalmology
Biopharmaceutical company Visus Therapeutics has acquired all patents and assets from eyecare developer ViewPoint Therapeutics.
Eyecare pharmaceutical company Harrow and anesthesia company Sintetica have developed an FDA-approved ocular surface anesthesia, Iheezo.
Former Santen CEO Adrienne Graves, PhD, has been appointed to the board of directors for retinal gene therapy research company Opus Genetics.
Payment platform CoFi partnered with financing company Alphaeon to launch a financing solution for ophthalmology practices.
Advertisement
From new partnerships to salary reports, here are the 10 most-read ophthalmology stories from Becker's during September.
The number of ophthalmologists in the U.S. has remained virtually unchanged since 1990, according to an August report from the American Academy of Ophthalmology.
California tops the list of states with the most ophthalmic medical technicians in the country, with 5,610, according to data from the Bureau of Labor Statistics.
Santen Inc., the U.S. subsidiary of Santen Pharmaceutical Co., and Ube Corp. have received FDA approval for their Omlonti 0.002 percent eye drops, which are designed to reduce elevated intraocular pressure in glaucoma patients.
Houston-based Whitsett Vision Group has become the first ophthalmology group in the country to perform a cataract surgery using a new FDA-approved lens, the Lenstec ClearView 3.